BZW2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.012580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.498200E-01
Normal-vs-Stage2
6.817600E-02
Normal-vs-Stage3
3.172000E-01
Normal-vs-Stage4
5.270100E-02
Stage1-vs-Stage2
5.816200E-01
Stage1-vs-Stage3
9.608400E-01
Stage1-vs-Stage4
3.134400E-01
Stage2-vs-Stage3
5.990600E-01
Stage2-vs-Stage4
3.049800E-01
Stage3-vs-Stage4
3.600200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.102780E-01
Normal-vs-AfricanAmerican
1.297840E-01
Normal-vs-Asian
3.950400E-02
Caucasian-vs-AfricanAmerican
9.531600E-01
Caucasian-vs-Asian
9.894000E-01
AfricanAmerican-vs-Asian
9.590200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.113900E-02
Normal-vs-Female
1.223850E-01
Male-vs-Female
3.522800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.153600E-01
Normal-vs-Age(41-60Yrs)
4.811700E-02
Normal-vs-Age(61-80Yrs)
1.400150E-01
Normal-vs-Age(81-100Yrs)
2.621900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.876200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.745200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.507400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.375400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.560360E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.663500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.512420E-01
Normal-vs-Daily Drinker
1.731190E-01
Normal-vs-Weekly Drinker
1.419620E-01
Normal-vs-Occasional Drinker
9.460300E-02
Normal-vs-Social Drinker
1.002420E-01
Non Drinker-vs-Daily Drinker
9.207000E-01
Non Drinker-vs-Weekly Drinker
6.594800E-01
Non Drinker-vs-Occasional Drinker
4.002000E-01
Non Drinker-vs-Social Drinker
8.085600E-01
Daily Drinker-vs-Weekly Drinker
6.223000E-01
Daily Drinker-vs-Occasional Drinker
3.847600E-01
Daily Drinker-vs-Social Drinker
8.882200E-01
Weekly Drinker-vs-Occasional Drinker
7.716400E-01
Weekly Drinker-vs-Social Drinker
5.326600E-01
Occasional Drinker-vs-Social Drinker
3.223400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.069000E-01
Normal-vs-Grade 2
9.826400E-01
Normal-vs-Grade 3
9.425200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.264930E-03
Grade 1-vs-Grade 3
8.757000E-04
Grade 1-vs-Grade 4
8.069000E-01
Grade 2-vs-Grade 3
1.732240E-01
Grade 2-vs-Grade 4
9.826400E-01
Grade 3-vs-Grade 4
9.425200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.287420E-01
Normal-vs-NonDiabetic
1.026850E-01
Diabetic-vs-NonDiabetic
6.010000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.464400E-02
Normal-vs-NoPancreatitis
1.207410E-01
Pancreatitis-vs-NoPancreatitis
4.084000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.058630E-01
Normal-vs-N1
7.952200E-02
N0-vs-N1
2.805800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.21399999842131E-08
Normal-vs-TP53-NonMutant
7.788600E-04
TP53-Mutant-vs-TP53-NonMutant
8.08200000035342E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
